MYC and neoplasm: Comparing the genome-wide profile of TGF-β gene responses in non-tumorigenic and tumor-derived human mammary cells, Chen et al.15 noted that the loss of TGF-β growth inhibitory effect in tumor-derived human mammary cells occurs with a selective loss of the corresponding c-MYC down-regulation.